Precision Diagnostics and Testing Technology Advancements: Growth Opportunities in Increased Adoption of Genomic Screening, Big Data and AI Augmentation & Discovery of Novel Biomarkers

DUBLIN, Feb. 15, 2024 /PRNewswire/ -- The "Technology Advancements in Precision Diagnostics and Testing" report has been added to ResearchAndMarkets.com's offering.

Precision diagnosis in today's healthcare is pivotal, tailoring treatment to individual patients based on genetic, molecular, and environmental factors. This targeted approach enhances accuracy, enables early detection and targeted treatment, minimizes trial-and-error treatment, and optimizes therapeutic outcomes.

By leveraging advanced technologies and personalized data, precision diagnosis empowers healthcare professionals to make informed decisions, improving patient care and fostering more effective and efficient healthcare delivery.

Cutting-edge precision diagnostic technologies are transforming the medical science and patient care landscape. These advanced methods meticulously analyze biological samples, such as blood, tissue, and genetic material, to accurately diagnose a range of diseases and conditions. The importance of precision diagnostic technology in healthcare lies in its ability to precisely identify diseases, reduce misdiagnoses, prevent unnecessary treatment, and enhance the effectiveness of targeted therapies. Ultimately, this contributes to improved patient outcomes.

Technology advancements around genomic sequencing, multi-omics, and AI and Big Data integration have boosted this space's growth.

This research service focuses on identifying different emerging technologies that enable precision diagnosis, key participants working on different technologies, and the applicability of precision diagnosis across different disease areas.

The report identifies 3 growth opportunities for precision diagnosis that could potentially transform the market.

Top 3 Growth Opportunities

• Increased Adoption of Genomic Screening
• Big Data and AI Augmentation
• Discovery of Novel Biomarkers

Key Questions Answered

• What are the drivers and challenges for precision diagnostics and testing development?
• How can precision diagnosis transform diagnosis across different disease areas?
• What does the mitochondrial therapeutics funding and partnership scenario look like?
• Who are the main precision diagnostics and testing innovators?
• What are the R&D trends in this space?
• What are the key growth opportunities?

Key Market Dynamics

• Public and Private Funding are Promoting Precision Diagnostics Development
• Precision Diagnostics Companies' Partnerships

Key Topics Covered:

Growth Opportunity Analysis

• Growth Drivers
• Growth Driver Analysis
• Growth Restraints
• Growth Restraint Analysis
• Scope and Segmentation
• Utility of Precision Diagnostics
• Liquid Biopsy in Precision Diagnosis
• Predictive Genetic Testing as an Effective Tool for Precision Testing
• Pharmacogenomics in Precision Diagnosis
• Technological Advancements in PCR
• Emerging Technologies Bolstering Precision Testing
• Emerging Technologies Enabling Precision Testing/Diagnosis

Precision Diagnostics: Application across Different Diseases

• The Role of Precision Testing in Oncology
• Technologies Enabling Precision Testing/Diagnosis for Oncology
• Novel Biomarkers Enabling Precision Medicine
• Microfluidic Devices Enabling Precision Medicine
• Innovation Spotlight - Precision Testing Technology for Oncology
• Recent CDx Approvals - Cancer Therapy Selection
• Infectious Diseases - The Need for Precision Testing
• Precision Testing Enables Infectious Disease Surveillance and Management
• Emerging Technologies for the Precision Testing of Infectious Diseases
• Molecular Diagnostics Enabling Precision Testing/Diagnosis for Infectious Diseases
• Multiplex Molecular POC Testing Enabling Precision Medicine
• Innovation Spotlight - Precision Testing Technology for Infectious Diseases
• Neurological Diseases - Challenges with Diagnostics
• How Precision Testing Helps Overcome Current Diagnostic Challenges
• Blood-based Biomarkers to Improve Neurodegenerative Disease Assessment
• Technologies Enabling Precision Testing/Diagnosis for Neurological Diseases
• Innovation Spotlight - Precision Testing Technology for Neurological Diseases
• CVDs - Current Testing Challenges and the Way Forward
• Molecular Diagnostics Enabling Precision Testing/Diagnosis for CVDs
• Innovation Spotlight - Precision Testing Technology for Neurological Diseases
• Genetic/Rare Diseases - Challenges With Diagnosis
• How Precision Testing Helps Overcome Current Diagnostic Challenges in Genetic/Rare Diseases
• Technologies Enabling Precision Testing/Diagnosis for Genetic/Rare Diseases

Enablers of Precision Diagnostics

• Enablers of Precision Diagnosis
• AI and ML in Precision Testing
• Application
• Big Data Analytics in Precision Testing

R&D Focus

• Strategic Imperatives to Bolster Precision Testing

For more information about this report visit https://www.researchandmarkets.com/r/357tpw

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected] 

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets